EMR posts solid Q4 results with stronger margins and upbeat FY26 guidance, driven by Software & Control growth.

Emerson Electric is completing a transformation into a technology- and software-driven automation company. Read why EMR stock is a Strong Buy.

While AI has accelerated drug discovery, the same technology can address clinical trial bottlenecks that have persisted for ...

As a reminder, Q1 2025 adjusted EPS of $1.38 included the benefit of several dynamics such as discretionary cost containment and favorable project closeouts in Control Systems & Software. It's also ...

Boston-based athenahealth introduced an AI-native clinical encounter that uses ambient and generative artificial intelligence to streamline documentation, decision-making and orders during the patient ...

AI-native clinical encounter, a reimagined experience that anticipates clinicians' needs, surfaces relevant insights at the moment of care, and drafts documentation, orders, and diagnoses based on the ...

Global Medical Transcription Software Market: Transforming Healthcare Documentation Through Innovation ...

Learn how CI/CD on cloud (AWS, Snowflake) plus Terraform & Airflow can speed releases, reduce MTTR, and improve reliability ...

Workers' Comp claim frequency dropped over 50% in 3-year NYC pilot of Arrowsight; top contractors Skanska, Suffolk, Gilbane, ...

Raintree, the leading provider of AI-powered software solutions for rehabilitation and physical therapy organizations, today announced the release of a groundbreaking new whitepaper in partnership ...

Detailed price information for Emerson Electric Company (EMR-N) from The Globe and Mail including charting and trades.